Nathalie Cools, Ph.D.
Affiliations: | 2007 | Universiteit Antwerpen (Belgium) |
Area:
ImmunologyGoogle:
"Nathalie Cools"Parents
Sign in to add mentor| Viggo V. Tendeloo | grad student | 2007 | Universiteit Antwerpen (Belgium) | |
| (Balancing between immunity and tolerance: Interplay between dendritic cells, effector T cells and regulatory T cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Van Genechten T, De Laere M, Van den Bossche J, et al. (2024) Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium. Bmj Open. 14: e077613 |
| Erdem R, De Coster I, Withanage K, et al. (2023) Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine |
| Van Delen M, Janssens I, Dams A, et al. (2022) Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner. International Journal of Molecular Sciences. 23 |
| Meena M, Van Delen M, De Laere M, et al. (2021) Transmigration across a Steady-State Blood-Brain Barrie Induces Activation of Circulating Dendritic Cells Partly Mediated by Actin Cytoskeletal Reorganization. Membranes. 11 |
| Janssens I, Cools N. (2020) Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity? Cellular Immunology. 358: 104236 |
| Maes E, Cools N, Willems H, et al. (2020) FACS-Based Proteomics Enables Profiling of Proteins in Rare Cell Populations. International Journal of Molecular Sciences. 21 |
| Willekens B, Presas-Rodríguez S, Mansilla MJ, et al. (2019) Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration. Bmj Open. 9: e030309 |
| Derdelinckx J, Mansilla MJ, De Laere M, et al. (2019) Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA. Journal of Neuroinflammation. 16: 167 |
| Meena M, Cools N. (2019) On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system. Neural Regeneration Research. 14: 2088-2090 |
| Ten Brinke A, Martinez-Llordella M, Cools N, et al. (2019) Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective. Frontiers in Immunology. 10: 181 |